Sofia Ajeganova

2.0k total citations
49 papers, 1.3k citations indexed

About

Sofia Ajeganova is a scholar working on Rheumatology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Sofia Ajeganova has authored 49 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Rheumatology, 20 papers in Immunology and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Sofia Ajeganova's work include Systemic Lupus Erythematosus Research (32 papers), Rheumatoid Arthritis Research and Therapies (26 papers) and Atherosclerosis and Cardiovascular Diseases (14 papers). Sofia Ajeganova is often cited by papers focused on Systemic Lupus Erythematosus Research (32 papers), Rheumatoid Arthritis Research and Therapies (26 papers) and Atherosclerosis and Cardiovascular Diseases (14 papers). Sofia Ajeganova collaborates with scholars based in Sweden, Belgium and Netherlands. Sofia Ajeganova's co-authors include Ingiäld Hafström, T. Huizinga, Johan Frostegård, Maria Andersson, Björn Svensson, Annette H M van der Helm–van Mil, Kristina Forslind, H.W. van Steenbergen, Leendert A. Trouw and Tomas Jogestrand and has published in prestigious journals such as Neurology, European Heart Journal and Annals of the Rheumatic Diseases.

In The Last Decade

Sofia Ajeganova

47 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sofia Ajeganova Sweden	22	984	352	221	200	150	49	1.3k
P. Nicaise‐Roland France	24	931 0.9×	396 1.1×	262 1.2×	156 0.8×	166 1.1×	56	1.5k
Farideh Alasti Austria	18	967 1.0×	421 1.2×	354 1.6×	111 0.6×	105 0.7×	41	1.2k
Francesca Bellisai Italy	21	611 0.6×	313 0.9×	171 0.8×	140 0.7×	147 1.0×	62	1.1k
Arturo Rodríguez de la Serna Spain	15	630 0.6×	224 0.6×	171 0.8×	93 0.5×	121 0.8×	35	1.2k
Loukas Settas Greece	16	819 0.8×	349 1.0×	358 1.6×	111 0.6×	255 1.7×	28	1.2k
Kyriaki Boki Greece	21	761 0.8×	347 1.0×	122 0.6×	135 0.7×	158 1.1×	54	1.2k
Hilde Swinkels Netherlands	8	1.2k 1.2×	164 0.5×	320 1.4×	237 1.2×	188 1.3×	9	1.3k
Tatiana Cobo‐Ibáñez Spain	18	719 0.7×	331 0.9×	212 1.0×	102 0.5×	100 0.7×	34	1.0k
Yehuda Shoenfeld Israel	17	949 1.0×	612 1.7×	280 1.3×	205 1.0×	198 1.3×	32	1.3k
Masao Nawata Japan	24	1.2k 1.2×	536 1.5×	344 1.6×	294 1.5×	255 1.7×	47	1.8k

Countries citing papers authored by Sofia Ajeganova

Since Specialization

Citations

This map shows the geographic impact of Sofia Ajeganova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofia Ajeganova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofia Ajeganova more than expected).

Fields of papers citing papers by Sofia Ajeganova

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sofia Ajeganova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofia Ajeganova. The network helps show where Sofia Ajeganova may publish in the future.

Co-authorship network of co-authors of Sofia Ajeganova

This figure shows the co-authorship network connecting the top 25 collaborators of Sofia Ajeganova. A scholar is included among the top collaborators of Sofia Ajeganova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sofia Ajeganova. Sofia Ajeganova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mo, Minjia, Maria Eriksdotter, Sofia Ajeganova, et al.. (2025). Association of Rheumatoid Arthritis With Progression of Cognitive Impairment and Risk of Mortality in People With Dementia. Neurology. 104(5). e213405–e213405. 1 indexed citations

Ajeganova, Sofia, Maria Andersson, Kristina Forslind, et al.. (2023). Long-term fracture risk in rheumatoid arthritis: impact of early sustained DAS28-remission and restored function, progressive erosive disease, body mass index, autoantibody positivity and glucocorticoids. A cohort study over 10 years. BMC Rheumatology. 7(1). 23–23. 10 indexed citations

Svensson, Björn, Maria Andersson, Inger Gjertsson, et al.. (2022). Erosion-free rheumatoid arthritis: clinical and conceptional implications—a BARFOT study. BMC Rheumatology. 6(1). 88–88. 11 indexed citations

Hafström, Ingiäld, Björn Svensson, Sofia Ajeganova, et al.. (2022). Misdiagnosis of Rheumatoid Arthritis in a Long-Term Cohort of Early Arthritis Based on the ACR-1987 Classification Criteria. Open Access Rheumatology Research and Reviews. Volume 14. 187–194. 4 indexed citations

Frostegård, Johan, Sabbir Ahmed, Ingiäld Hafström, Sofia Ajeganova, & Mizanur Rahman. (2021). Low levels of PCSK9 are associated with remission in patients with rheumatoid arthritis treated with anti-TNF-α: potential underlying mechanisms. Arthritis Research & Therapy. 23(1). 32–32. 25 indexed citations

Ajeganova, Sofia, Maria Andersson, Johan Frostegård, & Ingiäld Hafström. (2021). Higher levels of anti-phosphorylcholine autoantibodies in early rheumatoid arthritis indicate lower risk of incident cardiovascular events. Arthritis Research & Therapy. 23(1). 201–201. 4 indexed citations

Nilsson, Jenny, Maria Andersson, Ingiäld Hafström, et al.. (2021). Influence of Age and Sex on Disease Course and Treatment in Rheumatoid Arthritis. Open Access Rheumatology Research and Reviews. Volume 13. 123–138. 35 indexed citations

Hafström, Ingiäld, Sofia Ajeganova, Maria Andersson, et al.. (2019). <p>A Swedish register-based, long-term inception cohort study of patients with rheumatoid arthritis – results of clinical relevance</p>. Open Access Rheumatology Research and Reviews. Volume 11. 207–217. 20 indexed citations

Palomares, Óscar, Eva Untersmayr, Jan Gutermuth, et al.. (2019). Biologicals in allergic diseases and asthma: Toward personalized medicine and precision health: Highlights of the 3rd EAACI Master Class on Biologicals, San Lorenzo de El Escorial, Madrid, 2019. Allergy. 75(4). 936–940. 7 indexed citations

10.

Ajeganova, Sofia, Thomas Gustafsson, Tomas Jogestrand, Ingiäld Hafström, & Johan Frostegård. (2019). SAT0182 DYSLIPIDEMIA, HYPERTENSION, LUPUS NEPHRITIS AND HIGHER PREDNISONE USAGE CONTRIBUTE TO EVOLUTION OF CAROTID INTIMA-MEDIA THICKNESS IN MILD SYSTEMIC LUPUS ERYTHEMATOSUS: A 7-YEAR FOLLOW-UP STUDY. Annals of the Rheumatic Diseases. 78. 1165–1166. 1 indexed citations

11.

Hafström, Ingiäld, Sofia Ajeganova, Kristina Forslind, & Björn Svensson. (2019). Anti-citrullinated protein antibodies are associated with osteopenia but not with pain at diagnosis of rheumatoid arthritis: data from the BARFOT cohort. Arthritis Research & Therapy. 21(1). 45–45. 16 indexed citations

12.

Ajeganova, Sofia, Daniel Tesfa, Hans Hägglund, et al.. (2017). Effect of FCGR polymorphism on the occurrence of late-onset neutropenia and flare-free survival in rheumatic patients treated with rituximab. Arthritis Research & Therapy. 19(1). 44–44. 9 indexed citations

13.

Ajeganova, Sofia, H.W. van Steenbergen, Marije K. Verheul, et al.. (2016). The association between anti-carbamylated protein (anti-CarP) antibodies and radiographic progression in early rheumatoid arthritis: a study exploring replication and the added value to ACPA and rheumatoid factor. Annals of the Rheumatic Diseases. 76(1). 112–118. 67 indexed citations

14.

Ajeganova, Sofia, Jennifer Humphreys, Marije K. Verheul, et al.. (2016). Anticitrullinated protein antibodies and rheumatoid factor are associated with increased mortality but with different causes of death in patients with rheumatoid arthritis: a longitudinal study in three European cohorts. Annals of the Rheumatic Diseases. 75(11). 1924–1932. 61 indexed citations

15.

Ajeganova, Sofia, Jennifer Humphreys, Chikashi Terao, et al.. (2016). Smoking is associated with the concurrent presence of multiple autoantibodies in rheumatoid arthritis rather than with anti-citrullinated protein antibodies per se: a multicenter cohort study. Arthritis Research & Therapy. 18(1). 285–285. 48 indexed citations

16.

Ajeganova, Sofia, et al.. (2016). A four-week team-rehabilitation programme in a warm climate decreases disability and improves health and body function for up to one year: A prospective study in Swedish patients with inflammatory joint diseases. Journal of Rehabilitation Medicine. 48(8). 711–718. 5 indexed citations

17.

Ajeganova, Sofia, H.W. van Steenbergen, Jessica A B van Nies, et al.. (2015). Disease-modifying antirheumatic drug-free sustained remission in rheumatoid arthritis: an increasingly achievable outcome with subsidence of disease symptoms. Annals of the Rheumatic Diseases. 75(5). 867–873. 60 indexed citations

18.

Ajeganova, Sofia, et al.. (2014). Low-dose prednisolone treatment of early rheumatoid arthritis and late cardiovascular outcome and survival: 10-year follow-up of a 2-year randomised trial. BMJ Open. 4(4). e004259–e004259. 42 indexed citations

19.

Ajeganova, Sofia, et al.. (2012). Association of obesity with worse disease severity in rheumatoid arthritis as well as with comorbidities: A long‐term followup from disease onset. Arthritis Care & Research. 65(1). 78–87. 177 indexed citations

20.

Tesfa, Daniel, Sofia Ajeganova, Hans Hägglund, et al.. (2011). Late‐onset neutropenia following rituximab therapy in rheumatic diseases: Association with B lymphocyte depletion and infections. Arthritis & Rheumatism. 63(8). 2209–2214. 109 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact